organ functionimproved graft survival [197]no effect on hepatic biomarkers (ALT, AST, bilirubin) [197,198]higher frequency of post-hepatectomy liver failure (grade A) [198]trend towards lower frequency of post-hepatectomy liver failure (grade B&C) [198]trend towards reduced overall complications [198]no effect on duration of hospital stays [199]no effect on vascular complications [199]no effect on hepatic biomarkers (ALT, AST, bilirubin) [199]no effect on inotrope requirements [199]. The gene discussed is GPT; the disease is liver failure.